Serial healthcare entrepreneur GSK Velu, chairman & managing director of Trivitron group of companies (medical equipment group), has announced the setting up of two investment vehicles worth $175 million.
The funds will be divided between the recently launched Stakeboat Capital, a venture capital fund targeting to raise $100 million and a family office with a corpus of $75 million.
The fund will ride on major themes like healthcare delivery, consumer-led businesses and enterprise technology.
Velu will act as the non-executive chairman of Stakeboat Capital which will also include two General Partners (GPs) — private equity veteran Kandasamy Chandrasekar and A Ganesan, chartered accountant and a confidant of Velu . While Velu will be the anchor investor in the new fund, contributing $20 million, the remaining $80 million will be raised from domestic family offices and other domestic and international institutional investors.